Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06421766 · ClinicalTrials.gov registry record
Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures
A clinical trial, sponsored by Oticon Medical.
- Completed
- Registry status
- 234
- Enrollment target
NCT06421766 is a clinical trial that has completed, run by Oticon Medical. The registered enrollment target is 234 participants.
The verdict
NCT06421766 has completed, sponsored by Oticon Medical.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
This retrospective study is conducted to gain more knowledge on use and complications of 3mm long implants used in percutaneous (through the skin) bone-anchored hearing system (BAHS) surgeries in adults. Patients included have already been treated and recieved an implant with the wide diameter (Ø: 4.5 mm) design, either of 3- or 4mm length. The main purpose of the study is to investigate implant survival three months after implantation.
Interventions
- DEVICE BAHS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2024-09-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06421766
The ClinicalTrials.gov registry entry for NCT06421766 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oticon Medical, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BAHS is the first listed.
NCT06421766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06421766 about?
NCT06421766 is a clinical study titled "Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures". This retrospective study is conducted to gain more knowledge on use and complications of 3mm long implants used in percutaneous (through the skin) bone-anchored hearing system (BAHS) surgeries in adults. Patients included have already been treated and recieved an implant with the wide diameter (Ø: 4...
What is the current status of trial NCT06421766?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2024-03-08. Estimated completion is 2024-09-25.
What interventions are being tested in trial NCT06421766?
The interventions under investigation include: BAHS (DEVICE).
Who is sponsoring clinical trial NCT06421766?
This trial is sponsored by Oticon Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.